Chardan Capital Initiates Coverage On Agenus with Buy Rating, Announces Price Target of $40

9/18/2026
Impact: 75
Healthcare

Chardan Capital analyst Andreas Argyrides has initiated coverage on Agenus (NASDAQ: AGEN) with a Buy rating. The firm has set a price target of $40 for the stock.

AI summary, not financial advice

Share: